View in EDS HTML Full Text PDF Full Text

Tocilizumab and COVID-19: Timing of Administration and Efficacy.

Saved in:
Bibliographic Details
Title: Tocilizumab and COVID-19: Timing of Administration and Efficacy.
Authors: Abidi E; Department of Pharmacy Services, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates., El Nekidy WS; Department of Pharmacy Services, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates.; Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, United States., Alefishat E; Department of Pharmacology, College of Medicine and Health Science, Khalifa University, Abu Dhabi, United Arab Emirates.; Department of Biopharmaceutics and Clinical Pharmacy, Faculty of Pharmacy, The University of Jordan, Amman, Jordan.; Center for Biotechnology, Khalifa University of Science and Technology, Abu Dhabi, United Arab Emirates., Rahman N; Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, United States.; Critical Care Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates., Petroianu GA; Department of Pharmacology, College of Medicine and Health Science, Khalifa University, Abu Dhabi, United Arab Emirates., El-Lababidi R; Department of Pharmacy Services, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates., Mallat J; Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, United States.; Critical Care Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates.; Normandy University, UNICAEN, Caen, France.
Source: Frontiers in pharmacology [Front Pharmacol] 2022 Feb 18; Vol. 13, pp. 825749. Date of Electronic Publication: 2022 Feb 18 (Print Publication: 2022).
Publication Type: Journal Article; Review
Journal Info: Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 35250575
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Tocilizumab and COVID-19: Timing of Administration and Efficacy.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Abidi+E%22">Abidi E</searchLink>; Department of Pharmacy Services, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates.<br /><searchLink fieldCode="AU" term="%22El+Nekidy+WS%22">El Nekidy WS</searchLink>; Department of Pharmacy Services, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates.; Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, United States.<br /><searchLink fieldCode="AU" term="%22Alefishat+E%22">Alefishat E</searchLink>; Department of Pharmacology, College of Medicine and Health Science, Khalifa University, Abu Dhabi, United Arab Emirates.; Department of Biopharmaceutics and Clinical Pharmacy, Faculty of Pharmacy, The University of Jordan, Amman, Jordan.; Center for Biotechnology, Khalifa University of Science and Technology, Abu Dhabi, United Arab Emirates.<br /><searchLink fieldCode="AU" term="%22Rahman+N%22">Rahman N</searchLink>; Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, United States.; Critical Care Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates.<br /><searchLink fieldCode="AU" term="%22Petroianu+GA%22">Petroianu GA</searchLink>; Department of Pharmacology, College of Medicine and Health Science, Khalifa University, Abu Dhabi, United Arab Emirates.<br /><searchLink fieldCode="AU" term="%22El-Lababidi+R%22">El-Lababidi R</searchLink>; Department of Pharmacy Services, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates.<br /><searchLink fieldCode="AU" term="%22Mallat+J%22">Mallat J</searchLink>; Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, United States.; Critical Care Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates.; Normandy University, UNICAEN, Caen, France.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101548923%22">Frontiers in pharmacology</searchLink> [Front Pharmacol] 2022 Feb 18; Vol. 13, pp. 825749. <i>Date of Electronic Publication: </i>2022 Feb 18 (<i>Print Publication: </i>2022).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Media]%22">Frontiers Media] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101548923 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>1663-9812 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216639812%22">16639812 </searchLink><i>NLM ISO Abbreviation: </i>Front Pharmacol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35250575
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fphar.2022.825749
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 825749
    Titles:
      – TitleFull: Tocilizumab and COVID-19: Timing of Administration and Efficacy.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Abidi E
      – PersonEntity:
          Name:
            NameFull: El Nekidy WS
      – PersonEntity:
          Name:
            NameFull: Alefishat E
      – PersonEntity:
          Name:
            NameFull: Rahman N
      – PersonEntity:
          Name:
            NameFull: Petroianu GA
      – PersonEntity:
          Name:
            NameFull: El-Lababidi R
      – PersonEntity:
          Name:
            NameFull: Mallat J
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 18
              M: 02
              Text: 2022 Feb 18
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-print
              Value: 1663-9812
          Numbering:
            – Type: volume
              Value: 13
          Titles:
            – TitleFull: Frontiers in pharmacology
              Type: main
ResultId 1